ArticleJournal of molecular histology2026
LncRNA SNHG8 contributes to post-myocardial infarction cardiac fibrosis and is functionally associated with miR-192-3p.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Cardiac fibrosis is a major contributor to adverse ventricular remodeling after myocardial infarction (MI), but the non-coding RNA networks involved in fibroblast responses remain incompletely understood. We investigated the role of the long non-coding RNA SNHG8 in post-infarction cardiac fibrosis and its relationship with miR-192-3p using a murine MI model and angiotensin II (Ang II)-stimulated cardiac fibroblasts. SNHG8 expression was significantly increased in infarcted myocardium and in Ang II-treated fibroblasts. SNHG8 silencing reduced fibroblast proliferation and the expression of α-smooth muscle actin and collagen I, whereas SNHG8 overexpression produced the opposite effects in cultured fibroblasts. Dual-luciferase and rescue experiments supported a functional relationship between SNHG8 and miR-192-3p in vitro; however, these experiments do not establish an endogenous ceRNA mechanism or a validated downstream effector. In vivo, SNHG8 knockdown reduced post-MI scar burden and collagen I-positive area and partially preserved left ventricular systolic function. The role of miR-192-3p in mediating these in vivo effects was not tested. Together, the findings support a profibrotic role for SNHG8 in experimental post-MI remodeling and identify the SNHG8-miR-192-3p relationship as a candidate mechanism requiring further biochemical and in vivo validation.
Indexed as
Identifiers
42870056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.